TIDMGSK

RNS Number : 1864N

GlaxoSmithKline PLC

15 January 2019

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ===================================================================== 
 a)   Name                     Ms E N Walmsley 
===  ========================  =========================================== 
 b)   Position/status          Chief Executive Officer 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 10 January 2019. 
===  ========================  =========================================== 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP15.2875    1535.597 
                                               ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2019-01-11 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ===================================================================== 
 a)   Name                     Mr R G Connor 
===  ========================  =========================================== 
 b)   Position/status          President, Global Vaccines 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 10 January 2019. 
===  ========================  =========================================== 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP15.2875    42.320 
                                               ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2019-01-11 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them ('PCA') 
     ====================================================================== 
 a)   Name                      Mr S P Dingemans 
===  =========================  =========================================== 
 b)   Position/status           Chief Financial Officer 
===  =========================  =========================================== 
 c)   Initial notification/     Initial notification 
       amendment 
===  =========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ====================================================================== 
 a)   Name                      GlaxoSmithKline plc 
===  =========================  =========================================== 
 b)   LEI                       5493000HZTVUYLO1D793 
===  =========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ====================================================================== 
 a)   Description of            Ordinary shares of 25 pence each ('Ordinary 
       the financial             Shares') 
       instrument                ISIN: GB0009252882 
===  =========================  =========================================== 
 b)   Nature of the             Acquisition of Ordinary Shares following 
       transaction               the re-investment of dividends paid to 
                                 shareholders on 10 January 2019. 
===  =========================  =========================================== 
 c)   Price(s) and volume(s)      Price(s)      Volume(s) 
                                                ---------- 
                                   GBP15.2875    1050.550 
                                                ---------- 
===  =========================  =========================================== 
 d)   Aggregated information    n/a (single transaction) 
       Aggregated volume 
       Price 
===  =========================  =========================================== 
 e)   Date of the               2019-01-11 
       transaction 
===  =========================  =========================================== 
 f)   Place of the transaction  London Stock Exchange (XLON) 
===  =========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ===================================================================== 
 a)   Name                     Mr J Ford 
===  ========================  =========================================== 
 b)   Position/status          SVP & General Counsel 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 10 January 2019. 
===  ========================  =========================================== 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP15.2875    0.012 
                                               ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2019-01-11 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ========================================================================= 
 a)   Name                     Mr J Ford 
===  ========================  =============================================== 
 b)   Position/status          SVP & General Counsel 
===  ========================  =============================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ========================================================================= 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =============================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ========================================================================= 
 a)   Description of           American Depositary Shares ('ADSs') 
       the financial            ISIN: US37733W1053 
       instrument 
===  ========================  =============================================== 
 b)   Nature of the            Acquisition of ADSs following the re-investment 
       transaction              of dividends paid to shareholders on 10 
                                January 2019. 
===  ========================  =============================================== 
 c)   Price(s) and               Price(s)   Volume(s) 
       volume(s)                            ---------- 
                                  $39.4400   75.536 
                                            ---------- 
===  ========================  =============================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =============================================== 
 e)   Date of the transaction  2019-01-11 
===  ========================  =============================================== 
 f)   Place of the             New York Stock Exchange (XNYS) 
       transaction 
===  ========================  =============================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ===================================================================== 
 a)   Name                     Mr N Hirons 
===  ========================  =========================================== 
 b)   Position/status          SVP, Global Ethics & Compliance 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 10 January 2019. 
===  ========================  =========================================== 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP15.2875    309.578 
                                               ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2019-01-11 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ======================================================================= 
 a)   Name                   Mr N Hirons 
===  ======================  =============================================== 
 b)   Position/status        SVP, Global Ethics & Compliance 
===  ======================  =============================================== 
 c)   Initial notification/  Initial notification 
       amendment 
===  ======================  =============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================= 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  =============================================== 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  =============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================= 
 a)   Description             American Depositary Shares ('ADSs') 
       of the financial        ISIN: US37733W1053 
       instrument 
===  ======================  =============================================== 
 b)   Nature of the          Acquisition of ADSs following the re-investment 
       transaction            of dividends paid to shareholders on 10 
                              January 2019 
===  ======================  =============================================== 
 c)   Price(s) and             Price(s)   Volume(s) 
       volume(s)                          ---------- 
                                $39.4400   18.799 
                                          ---------- 
===  ======================  =============================================== 
 d)   Aggregated             n/a (single transaction) 
       information 
       Aggregated 
       volume Price 
===  ======================  =============================================== 
 e)   Date of the            2019-01-11 
       transaction 
===  ======================  =============================================== 
 f)   Place of the           New York Stock Exchange (XNYS) 
       transaction 
===  ======================  =============================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ======================================================================== 
 a)   Name                    Mr B McNamara 
===  =======================  =============================================== 
 b)   Position/status         CEO, GSK Consumer Healthcare 
===  =======================  =============================================== 
 c)   Initial notification/   Initial notification 
       amendment 
===  =======================  =============================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ======================================================================== 
 a)   Name                    GlaxoSmithKline plc 
===  =======================  =============================================== 
 b)   LEI                     5493000HZTVUYLO1D793 
===  =======================  =============================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ======================================================================== 
 a)   Description              American Depositary Shares ('ADSs') 
       of the financial         ISIN: US37733W1053 
       instrument 
===  =======================  =============================================== 
 b)   Nature of the           Acquisition of ADSs following the re-investment 
       transaction             of dividends paid to shareholders on 10 
                               January 2019 
===  =======================  =============================================== 
 c)   Price(s) and              Price(s)   Volume(s) 
       volume(s)                           ---------- 
                                 $39.4400   424.074 
                                           ---------- 
===  =======================  =============================================== 
 d)   Aggregated information  n/a (single transaction) 
       Aggregated volume 
       Price 
===  =======================  =============================================== 
 e)   Date of the             2019-01-11 
       transaction 
===  =======================  =============================================== 
 f)   Place of the            New York Stock Exchange (XNYS) 
       transaction 
===  =======================  =============================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ===================================================================== 
 a)   Name                     Mr D Redfern 
===  ========================  =========================================== 
 b)   Position/status          Chief Strategy Officer 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 10 January 2019. 
===  ========================  =========================================== 
 c)   Price(s) and               Price(s)     Volume(s) 
       volume(s)                              ---------- 
                                  GBP15.2875   1945.478 
                                              ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2019-01-11 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ===================================================================== 
 a)   Name                     Mr R Simard 
===  ========================  =========================================== 
 b)   Position/status          President, Pharma Supply Chain 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 10 January 2019. 
===  ========================  =========================================== 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP15.2875    363.181 
                                               ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2019-01-11 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ===================================================================== 
 a)   Name                     Ms C Thomas 
===  ========================  =========================================== 
 b)   Position/status          SVP, Human Resources 
===  ========================  =========================================== 
 c)   Initial notification/    Initial notification 
       amendment 
===  ========================  =========================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ===================================================================== 
 a)   Name                     GlaxoSmithKline plc 
===  ========================  =========================================== 
 b)   LEI                      5493000HZTVUYLO1D793 
===  ========================  =========================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ===================================================================== 
 a)   Description of           Ordinary shares of 25 pence each ('Ordinary 
       the financial            Shares') 
       instrument               ISIN: GB0009252882 
===  ========================  =========================================== 
 b)   Nature of the            Acquisition of Ordinary Shares following 
       transaction              the re-investment of dividends paid to 
                                shareholders on 10 January 2019. 
===  ========================  =========================================== 
 c)   Price(s) and               Price(s)      Volume(s) 
       volume(s)                               ---------- 
                                  GBP15.2875    357.061 
                                               ---------- 
===  ========================  =========================================== 
 d)   Aggregated information   n/a (single transaction) 
       Aggregated volume 
       Price 
===  ========================  =========================================== 
 e)   Date of the transaction  2019-01-11 
===  ========================  =========================================== 
 f)   Place of the             London Stock Exchange (XLON) 
       transaction 
===  ========================  =========================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ============================================================================ 
 a)   Name                   Mr P C Thomson 
===  ======================  ==================================================== 
 b)   Position/status        President, Global Affairs 
===  ======================  ==================================================== 
 c)   Initial notification/  Initial notification 
       amendment 
===  ======================  ==================================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ============================================================================ 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ==================================================== 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ==================================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ============================================================================ 
 a)   Description            Ordinary shares of 25 pence each ('Ordinary 
       of the financial       Shares') 
       instrument             ISIN: GB0009252882 
===  ======================  ==================================================== 
 b)   Nature of the          Acquisition of Ordinary Shares following 
       transaction            the re-investment of dividends paid to shareholders 
                              on 10 January 2019. 
===  ======================  ==================================================== 
 c)   Price(s) and             Price(s)      Volume(s) 
       volume(s)                             ---------- 
                                GBP15.2875    210.297 
                                             ---------- 
===  ======================  ==================================================== 
 d)   Aggregated             n/a (single transaction) 
       information 
       Aggregated 
       volume Price 
===  ======================  ==================================================== 
 e)   Date of the            2019-01-11 
       transaction 
===  ======================  ==================================================== 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ==================================================== 
 
 
 1.   Details of PDMR/person closely associated with them 
       ('PCA') 
     ============================================================================ 
 a)   Name                   Mrs K Thomson 
===  ======================  ==================================================== 
 b)   Position/status        PCA of Mr P C Thomson (President, Global 
                              Affairs) 
===  ======================  ==================================================== 
 c)   Initial notification/  Initial notification 
       amendment 
===  ======================  ==================================================== 
 2.   Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
===  ============================================================================ 
 a)   Name                   GlaxoSmithKline plc 
===  ======================  ==================================================== 
 b)   LEI                    5493000HZTVUYLO1D793 
===  ======================  ==================================================== 
 3.   Details of the transaction(s): section to be repeated 
       for (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transaction(s) 
       has been conducted 
===  ============================================================================ 
 a)   Description            Ordinary shares of 25 pence each ('Ordinary 
       of the financial       Shares') 
       instrument             ISIN: GB0009252882 
===  ======================  ==================================================== 
 b)   Nature of the          Acquisition of Ordinary Shares following 
       transaction            the re-investment of dividends paid to shareholders 
                              on 10 January 2019. 
===  ======================  ==================================================== 
 c)   Price(s) and             Price(s)      Volume(s) 
       volume(s)                             ---------- 
                                GBP15.2875    127.445 
                                             ---------- 
===  ======================  ==================================================== 
 d)   Aggregated             n/a (single transaction) 
       information 
       Aggregated 
       volume Price 
===  ======================  ==================================================== 
 e)   Date of the            2019-01-11 
       transaction 
===  ======================  ==================================================== 
 f)   Place of the           London Stock Exchange (XLON) 
       transaction 
===  ======================  ==================================================== 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHDELFFKFFFBBX

(END) Dow Jones Newswires

January 15, 2019 12:15 ET (17:15 GMT)

Gsk (LSE:GSK)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Gsk Charts.
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Gsk Charts.